<p><em>联合创始人兼董事长凯文·C·克拉克重返首席执行官职位</em></p>
<p>佛罗里达州博卡拉顿 --（商业新闻）--Cross Country Healthcare, Inc.（“公司” 和 “Cross Country”）（纳斯达克：CCRN）今天宣布，公司总裁兼首席执行官约翰·A·马丁斯已与公司分离，并于 2025 年 12 月 14 日起不再担任董事会成员（“董事会”）。董事会任命公司现任董事长、前首席执行官及联合创始人凯文·C·克拉克接替马丁斯先生担任公司总裁兼首席执行官。克拉克先生将继续担任董事会主席。</p>
<p>Cross Country 的首席独立董事拉里·卡什表示：“董事会成员对凯文重返 Cross Country 担任首席执行官感到非常兴奋，期待开启新的增长篇章。凯文在医疗保健人力资源行业拥有近 40 年的经验。他于 1986 年共同创立了 Cross Country，并在 1994 年之前担任董事长和首席执行官，2019 年至 2022 年再次担任首席执行官，期间实现了快速增长和强劲的财务业绩。从 2002 年到 2015 年，他共同创立了 Onward Healthcare，这是一家领先的旅行护士、辅助医疗和临时工作公司，并领导 Locum Leaders 和 Medefis，直到这三家公司在 2015 年被收购。”</p>
<p>除了在医疗保健人力资源和劳动力解决方案方面的丰富经验外，克拉克先生还建立并领导了其他创新的人力资源、营销和技术公司。凯文在变革性领导和运营卓越方面有着良好的记录。他是引领 Cross Country 进入下一个财务增长阶段的合适领导者。</p>
<p>卡什先生继续说道：“凯文是一位非凡的领导者，他的热情和愿景将为 Cross Country 带来一个以创新 AI 驱动、技术赋能的劳动力解决方案的新纪元。鉴于与 Aya Healthcare 交易的终止，董事会认为现在是首席执行官过渡的合适时机。我们代表整个董事会感谢约翰为公司所做的服务和贡献。”</p>
<p>克拉克先生表示：“我相信 Cross Country 及其未来，能够重返首席执行官职位我感到荣幸。” 他继续说道：“Cross Country 正处于一个关键时刻，有机会重新定义其作为创新技术驱动的劳动力解决方案领导者的轨迹，建立在近 40 年的行业标志性品牌遗产之上。我们的强大价值主张结合了信任、持续的质量、临床卓越和深厚的客户关系，以及现代数字平台和数据驱动的解决方案，帮助我们的客户解决最复杂的劳动力挑战。我们将聚焦核心，降低服务成本，优化资本配置策略，以便进行有意义、规范的投资，推动可持续的长期盈利增长，为我们的股东创造价值。”</p>
<p><strong>关于 Cross Country Healthcare</strong></p>
<p>Cross Country Healthcare, Inc.是一家市场领先的技术驱动的劳动力解决方案和咨询公司，拥有近 40 年的行业经验和洞察力。我们帮助客户应对复杂的劳动相关挑战，实现高质量的结果，同时通过数据驱动的洞察力减少复杂性并提高可见性。该公司及其他新闻稿的副本可以在线访问，网址为 <strong>ir.crosscountry.com</strong>。股东和潜在投资者还可以注册以自动接收公司的新闻稿、向证券交易委员会（SEC）提交的文件和其他通知。</p>
<p><strong>前瞻性声明。</strong></p>
<p>本新闻稿包含 1995 年《私人证券诉讼改革法案》中的 “前瞻性声明”。本新闻稿中包含的任何非历史事实的声明，包括与公司的未来业绩、表现和计划相关的声明，可能被视为前瞻性声明。所有这些前瞻性声明旨在提供管理层基于当前对公司业务、经济和其他未来条件的预期和假设的未来期望。前瞻性声明通常可以通过使用诸如 “相信”、“预期”、“可能”、“应该”、“将”、“计划”、“项目”、“期望”、“预期”、“估计”、“预测”、“目标”、“前景”、“战略”、“迹象” 等词语以及与未来表现、计划、行动或事件讨论相关的其他类似含义的词语来识别。由于前瞻性声明涉及未来，因此它们受到固有风险、不确定性和难以预测的情况变化的影响。这些风险和不确定性包括但不限于：(i) 与提议的与 Aya Healthcare, Inc.合并终止相关的风险；(ii) 与此处讨论的首席执行官过渡相关的风险，包括公司保留客户和留住及招聘关键人员以及维持与供应商和客户关系的能力；(iii) 影响公司业务服务市场的全球经济或政治变化，这可能对公司服务的需求产生影响并影响公司的盈利能力；(iv) 全球大流行、流行病或其他公共卫生危机的影响；(v) 市场条件的变化，例如替代医疗服务交付方式、报销和客户需求；以及 (vi) 全球信贷和金融市场的干扰，包括流动性和信贷可用性的减少、国际贸易协议的变化，包括关税和贸易限制、网络安全漏洞、外汇波动、消费者信心和支出的波动、提供服务的成本、关键员工的留存以及法律程序、索赔和调查的结果。因此，实际结果可能与这些前瞻性声明所设想的结果有重大差异。因此，投资者应谨慎对待依赖这些前瞻性声明。它们既不是历史事实的陈述，也不是未来表现的保证或保证。有关可能导致实际结果与这些前瞻性声明有重大差异的因素的更多信息，请参阅公司向美国证券交易委员会（SEC）提交的文件，包括在截至 2024 年 12 月 31 日的年度报告的第 I 部分，第 1A 项 - 风险因素中识别的风险和不确定性，以及公司向 SEC 提交的其他文件。该因素列表并不旨在详尽无遗。这些前瞻性声明仅在本新闻稿日期时有效，公司不承担更新或修订本新闻稿中所作的任何前瞻性声明或可能不时由公司或代表公司作出的前瞻性声明的义务，除非适用法律要求。</p>
<p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTEyMTQzNDI1NTdyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTEyMTQzNDI1NTdyMQ"/></p>
<p>在 businesswire.com 查看源版本：https://www.businesswire.com/news/home/20251214342557/en/</p>
<p>投资者：</p>
<p>William J. Burns，执行副总裁兼首席财务官</p>
<p>561-237-2555</p>
<p>wburns@crosscountry.com</p>
<p>Josh Vogel，副总裁，投资者关系</p>
<p>561-237-8310</p>
<p>jvogel@crosscountry.com</p>
<p>来源：Cross Country Healthcare, Inc.</p>

Cross Country医疗保健

<p>Cross Country Healthcare 宣布了首席执行官的交接，联合创始人兼董事长 Kevin C. Clark 将重新担任首席执行官，接替 John A. Martins。此次交接是在与 Aya Healthcare 合并终止后进行的。Clark 拥有丰富的医疗行业人力资源经验，旨在引领公司进入一个新的增长和创新时代，专注于技术驱动的劳动力解决方案。董事会对 Clark 的领导能力表示信心，认为他能够推动可持续的长期增长</p>

<p><em>Co-Founder and Chairman, Kevin C. Clark, Returns as Chief Executive Officer</em></p>
<div class="lb-trans"><p><em>联合创始人兼董事长凯文·C·克拉克重返首席执行官职位</em></p>
</div><p>BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company” and “Cross Country”) (Nasdaq: CCRN) today announced that John A. Martins, the Company’s President and Chief Executive Officer, has separated from the Company and ceased to serve as a member of its Board of Directors (the “Board”), effective as of December 14, 2025. The Board appointed Kevin C. Clark, the Company’s current Chairman, former Chief Executive Officer, and Co-Founder, to succeed Mr. Martins as the Company’s President and Chief Executive Officer. Mr. Clark will continue to serve as the Chairman of the Board.</p>
<div class="lb-trans"><p>佛罗里达州博卡拉顿 --（商业新闻）--Cross Country Healthcare, Inc.（“公司” 和 “Cross Country”）（纳斯达克：CCRN）今天宣布，公司总裁兼首席执行官约翰·A·马丁斯已与公司分离，并于 2025 年 12 月 14 日起不再担任董事会成员（“董事会”）。董事会任命公司现任董事长、前首席执行官及联合创始人凯文·C·克拉克接替马丁斯先生担任公司总裁兼首席执行官。克拉克先生将继续担任董事会主席。</p>
</div><p>“The Board members are thrilled to have Kevin return as Cross Country’s CEO to embark on a new chapter of growth,” said Cross Country’s Lead Independent Director, Larry Cash. “Kevin brings nearly 40 years of experience in the healthcare staffing industry. He co-founded Cross Country in 1986, serving as Chairman and CEO until 1994 and he returned to lead Cross Country as its CEO from 2019 to 2022, which resulted in a period of rapid growth and strong financial results. From 2002 to 2015, he co-founded Onward Healthcare, a leading travel nurse, allied health and per diem company, and also led Locum Leaders and Medefis until all three were acquired in 2015.”</p>
<div class="lb-trans"><p>Cross Country 的首席独立董事拉里·卡什表示：“董事会成员对凯文重返 Cross Country 担任首席执行官感到非常兴奋，期待开启新的增长篇章。凯文在医疗保健人力资源行业拥有近 40 年的经验。他于 1986 年共同创立了 Cross Country，并在 1994 年之前担任董事长和首席执行官，2019 年至 2022 年再次担任首席执行官，期间实现了快速增长和强劲的财务业绩。从 2002 年到 2015 年，他共同创立了 Onward Healthcare，这是一家领先的旅行护士、辅助医疗和临时工作公司，并领导 Locum Leaders 和 Medefis，直到这三家公司在 2015 年被收购。”</p>
</div><p>In addition to his significant healthcare staffing and workforce solutions experience, Mr. Clark has built and led other innovative staffing, marketing and technology companies. Kevin has a proven record of transformative leadership and operational excellence. He is the right leader to chart Cross Country’s next phase of financial growth.</p>
<div class="lb-trans"><p>除了在医疗保健人力资源和劳动力解决方案方面的丰富经验外，克拉克先生还建立并领导了其他创新的人力资源、营销和技术公司。凯文在变革性领导和运营卓越方面有着良好的记录。他是引领 Cross Country 进入下一个财务增长阶段的合适领导者。</p>
</div><p>Mr. Cash continued, “Kevin is an extraordinary leader whose passion and vision will usher in a new era of innovative AI-led, tech-enabled workforce solutions at Cross Country. In light of the termination of the transaction with Aya Healthcare, the Board believes that it is the right time for a CEO transition. On behalf of the entire Board, we thank John for his service and contributions to the Company.”</p>
<div class="lb-trans"><p>卡什先生继续说道：“凯文是一位非凡的领导者，他的热情和愿景将为 Cross Country 带来一个以创新 AI 驱动、技术赋能的劳动力解决方案的新纪元。鉴于与 Aya Healthcare 交易的终止，董事会认为现在是首席执行官过渡的合适时机。我们代表整个董事会感谢约翰为公司所做的服务和贡献。”</p>
</div><p>“I believe in Cross Country and its future, and I am honored to be returning as its CEO,” said Mr. Clark. He continued, “Cross Country stands at a pivotal moment, with the opportunity to redefine its trajectory as an innovative tech-enabled workforce solutions leader built on a nearly 40-year legacy as an iconic brand in our industry. Our strong value proposition combines trust, unrelenting quality, clinical excellence and deep client relationships with modern digital platforms and data driven solutions that help our clients solve their most complex workforce challenges. We will sharpen our focus, reduce our costs to serve, and optimize our capital allocation strategy so we can make meaningful, disciplined investments that drive sustainable, long‑term profitable growth for our shareholders.”</p>
<div class="lb-trans"><p>克拉克先生表示：“我相信 Cross Country 及其未来，能够重返首席执行官职位我感到荣幸。” 他继续说道：“Cross Country 正处于一个关键时刻，有机会重新定义其作为创新技术驱动的劳动力解决方案领导者的轨迹，建立在近 40 年的行业标志性品牌遗产之上。我们的强大价值主张结合了信任、持续的质量、临床卓越和深厚的客户关系，以及现代数字平台和数据驱动的解决方案，帮助我们的客户解决最复杂的劳动力挑战。我们将聚焦核心，降低服务成本，优化资本配置策略，以便进行有意义、规范的投资，推动可持续的长期盈利增长，为我们的股东创造价值。”</p>
</div><p><strong>About Cross Country Healthcare</strong></p>
<div class="lb-trans"><p><strong>关于 Cross Country Healthcare</strong></p>
</div><p>Cross Country Healthcare, Inc. is a market-leading, tech-enabled workforce solutions and advisory firm with nearly 40 years of industry experience and insight. We help clients tackle complex labor-related challenges and achieve high-quality outcomes, while reducing complexity and improving visibility through data driven insights. Copies of this and other press releases, information about the Company, can be accessed online at <strong>ir.crosscountry.com</strong>. Stockholders and prospective investors can also register to automatically receive the Company’s press releases, filings with the Securities and Exchange Commission (SEC), and other notices by e-mail.</p>
<div class="lb-trans"><p>Cross Country Healthcare, Inc.是一家市场领先的技术驱动的劳动力解决方案和咨询公司，拥有近 40 年的行业经验和洞察力。我们帮助客户应对复杂的劳动相关挑战，实现高质量的结果，同时通过数据驱动的洞察力减少复杂性并提高可见性。该公司及其他新闻稿的副本可以在线访问，网址为 <strong>ir.crosscountry.com</strong>。股东和潜在投资者还可以注册以自动接收公司的新闻稿、向证券交易委员会（SEC）提交的文件和其他通知。</p>
</div><p><strong>Forward-Looking Statements.</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明。</strong></p>
</div><p>This press release contains “forward-looking statements” within the Private Securities Litigation Reform Act of 1995. Any statements contained in this press release that are not statements of historical fact, including statements relating to the Company’s future results, performance, and plans, may be deemed to be forward-looking statements. All such forward-looking statements are intended to provide management’s current expectations for the future of the Company based on current expectations and assumptions relating to the Company’s business, the economy, and other future conditions. Forward-looking statements generally can be identified through the use of words such as “believes,” “anticipates,” “may,” “should,” “will,” “plans,” “projects,” “expects,” “expectations,” “estimates,” “forecasts,” “predicts,” “targets,” “prospects,” “strategy,” “signs,” and other words of similar meaning in connection with the discussion of future performance, plans, actions or events. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and changes in circumstances that are difficult to predict. Such risks and uncertainties include, among others: (i) risks related to the termination of the proposed merger with Aya Healthcare, Inc., (ii) risks related to the CEO transition discussed herein, including the Company’s ability to retain customers and retain and hire key personnel and maintain relationships with its suppliers and customers, (iii) worldwide economic or political changes that affect the markets that the Company’s businesses serve which could have an effect on demand for the Company’s services and impact the Company’s profitability, (iv) effects from global pandemics, epidemics, or other public health crises, (v) changes in marketplace conditions, such as alternative modes of healthcare delivery, reimbursement, and customer needs, and (vi) disruptions in the global credit and financial markets, including diminished liquidity and credit availability, changes in international trade agreements, including tariffs and trade restrictions, cyber-security vulnerabilities, foreign currency volatility, swings in consumer confidence and spending, costs of providing services, retention of key employees, and outcomes of legal proceedings, claims, and investigations. Accordingly, actual results may differ materially from those contemplated by these forward-looking statements. Investors, therefore, are cautioned against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company’s filings with the SEC, including the risks and uncertainties identified in Part I, Item 1A - Risk Factors of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, as amended by Amendment No. 1 on Form 10-K/A, and in the Company’s other filings with the SEC. The list of factors is not intended to be exhaustive. These forward-looking statements speak only as of the date of this press release, and the Company does not assume any obligation to update or revise any forward-looking statement made in this press release or that may from time to time be made by or on behalf of the Company, except as may be required by applicable law.</p>
<div class="lb-trans"><p>本新闻稿包含 1995 年《私人证券诉讼改革法案》中的 “前瞻性声明”。本新闻稿中包含的任何非历史事实的声明，包括与公司的未来业绩、表现和计划相关的声明，可能被视为前瞻性声明。所有这些前瞻性声明旨在提供管理层基于当前对公司业务、经济和其他未来条件的预期和假设的未来期望。前瞻性声明通常可以通过使用诸如 “相信”、“预期”、“可能”、“应该”、“将”、“计划”、“项目”、“期望”、“预期”、“估计”、“预测”、“目标”、“前景”、“战略”、“迹象” 等词语以及与未来表现、计划、行动或事件讨论相关的其他类似含义的词语来识别。由于前瞻性声明涉及未来，因此它们受到固有风险、不确定性和难以预测的情况变化的影响。这些风险和不确定性包括但不限于：(i) 与提议的与 Aya Healthcare, Inc.合并终止相关的风险；(ii) 与此处讨论的首席执行官过渡相关的风险，包括公司保留客户和留住及招聘关键人员以及维持与供应商和客户关系的能力；(iii) 影响公司业务服务市场的全球经济或政治变化，这可能对公司服务的需求产生影响并影响公司的盈利能力；(iv) 全球大流行、流行病或其他公共卫生危机的影响；(v) 市场条件的变化，例如替代医疗服务交付方式、报销和客户需求；以及 (vi) 全球信贷和金融市场的干扰，包括流动性和信贷可用性的减少、国际贸易协议的变化，包括关税和贸易限制、网络安全漏洞、外汇波动、消费者信心和支出的波动、提供服务的成本、关键员工的留存以及法律程序、索赔和调查的结果。因此，实际结果可能与这些前瞻性声明所设想的结果有重大差异。因此，投资者应谨慎对待依赖这些前瞻性声明。它们既不是历史事实的陈述，也不是未来表现的保证或保证。有关可能导致实际结果与这些前瞻性声明有重大差异的因素的更多信息，请参阅公司向美国证券交易委员会（SEC）提交的文件，包括在截至 2024 年 12 月 31 日的年度报告的第 I 部分，第 1A 项 - 风险因素中识别的风险和不确定性，以及公司向 SEC 提交的其他文件。该因素列表并不旨在详尽无遗。这些前瞻性声明仅在本新闻稿日期时有效，公司不承担更新或修订本新闻稿中所作的任何前瞻性声明或可能不时由公司或代表公司作出的前瞻性声明的义务，除非适用法律要求。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNTEyMTQzNDI1NTdyMQ" alt="" original-src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20251214342557r1&amp;sid=acqr8&amp;distro=nx&amp;lang=en"/></p>
<p>View source version on businesswire.com: https://www.businesswire.com/news/home/20251214342557/en/</p>
<div class="lb-trans"><p>在 businesswire.com 查看源版本：https://www.businesswire.com/news/home/20251214342557/en/</p>
</div><p>Investors:</p>
<div class="lb-trans"><p>投资者：</p>
</div><p>William J. Burns, EVP and CFO</p>
<div class="lb-trans"><p>William J. Burns，执行副总裁兼首席财务官</p>
</div><p>561-237-2555</p>
<div class="lb-trans"><p>561-237-2555</p>
</div><p>wburns@crosscountry.com</p>
<div class="lb-trans"><p>wburns@crosscountry.com</p>
</div><p>Josh Vogel, VP, Investor Relations</p>
<div class="lb-trans"><p>Josh Vogel，副总裁，投资者关系</p>
</div><p>561-237-8310</p>
<div class="lb-trans"><p>561-237-8310</p>
</div><p>jvogel@crosscountry.com</p>
<div class="lb-trans"><p>jvogel@crosscountry.com</p>
</div><p>Source: Cross Country Healthcare, Inc.</p>
<div class="lb-trans"><p>来源：Cross Country Healthcare, Inc.</p>
</div>

Cross Country 医疗保健宣布 CEO 职位变动 | CCRN 股票新闻